184 related articles for article (PubMed ID: 10179343)
1. Establishment registration and listing for manufacturers of human cellular and tissue-based products--FDA. Proposed rule.
Fed Regist; 1998 May; 63(93):26744-55. PubMed ID: 10179343
[TBL] [Abstract][Full Text] [Related]
2. Establishment registration and listing for manufacturers of human cellular and tissue-based products--FDA. Proposed rule; reopening of comment period.
Fed Regist; 1998 Dec; 63(237):68212-3. PubMed ID: 10338885
[TBL] [Abstract][Full Text] [Related]
3. Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2001 Jan; 66(13):5447-69. PubMed ID: 11503777
[TBL] [Abstract][Full Text] [Related]
4. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; companion to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Sep; 63(188):51874-5. PubMed ID: 10185813
[TBL] [Abstract][Full Text] [Related]
5. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; correction--FDA. Proposed rule; correction.
Fed Regist; 1998 Nov; 63(228):65566. PubMed ID: 10338876
[TBL] [Abstract][Full Text] [Related]
6. Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule.
Fed Regist; 1998 Sep; 63(188):51825-7. PubMed ID: 10185812
[TBL] [Abstract][Full Text] [Related]
7. Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license--FDA. Proposed rule.
Fed Regist; 1998 Jul; 63(147):40858-71. PubMed ID: 10181717
[TBL] [Abstract][Full Text] [Related]
8. Current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; inspection and enforcement. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Nov; 69(226):68611-88. PubMed ID: 15562555
[TBL] [Abstract][Full Text] [Related]
9. Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license; correction--FDA. Proposed rule; correction.
Fed Regist; 1998 Sep; 63(170):46718. PubMed ID: 10182705
[TBL] [Abstract][Full Text] [Related]
10. Medical devices; preemption of state product liability claims--FDA. Proposed rule.
Fed Regist; 1997 Dec; 62(239):65384-8. PubMed ID: 10176832
[TBL] [Abstract][Full Text] [Related]
11. Foreign establishment registration and listing. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2001 Nov; 66(228):59138-61. PubMed ID: 11776289
[TBL] [Abstract][Full Text] [Related]
12. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; correction--FDA. Direct final rule; correction.
Fed Regist; 1998 Nov; 63(228):65554-5. PubMed ID: 10338874
[TBL] [Abstract][Full Text] [Related]
13. Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. Interim final rule; opportunity for public comment.
Food and Drug Administration, HHS
Fed Regist; 2004 Jan; 69(17):3823-6. PubMed ID: 14968801
[TBL] [Abstract][Full Text] [Related]
14. Letter to manufacturers of blood establishment computer software products--FDA. Notice.
Fed Regist; 1994 Aug; 59(168):44991-2. PubMed ID: 10136917
[TBL] [Abstract][Full Text] [Related]
15. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 May; 69(101):29785-834. PubMed ID: 15160713
[TBL] [Abstract][Full Text] [Related]
16. Biologics products; establishment registration and product listing for manufacturers of human blood and blood products; amendment to exempt certain transfusion services from registration--FDA. Final rule.
Fed Regist; 1984 Aug; 49(171):34448-51. PubMed ID: 10299643
[TBL] [Abstract][Full Text] [Related]
17. Medical devices; preemption of state product liability claims--FDA. Withdrawal of proposed rule.
Fed Regist; 1998 Jul; 63(142):39789-90. PubMed ID: 10181516
[TBL] [Abstract][Full Text] [Related]
18. Revisions to the general safety requirements for biological products; companion document to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Apr; 63(75):19431-4. PubMed ID: 10178870
[TBL] [Abstract][Full Text] [Related]
19. Biological products: reporting of biological product deviations in manufacturing. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Nov; 65(216):66621-35. PubMed ID: 11503696
[TBL] [Abstract][Full Text] [Related]
20. Natural rubber-containing medical devices; user labelling--FDA. Final rule; interpretation.
Fed Regist; 1998 May; 63(87):24934-5. PubMed ID: 10179326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
